Pharvaris is a Nasdaq listed late-stage biotech company developing bradykinin B2 receptor antagonists for bradykinin-mediated diseases, with offices inSwitzerland(Zug), theNetherlands(Leiden) and theU...
Pharvaris is a Nasdaq listed late-stage biotech company developing bradykinin B2 receptor antagonists for bradykinin-mediated diseases, with offices inSwitzerland(Zug), theNetherlands(Leiden) and theU...